Breast Cancer News and Research

Latest Breast Cancer News and Research

CHMP adopts positive opinion on pending MAA for SYCREST sublingual tablets

Merck announced that the Committee for Medicinal Products for Human Use adopted a positive opinion on the pending Marketing Authorization Application for SYCREST (asenapine) sublingual tablets. The CHMP has recommended that the European Commission grant a marketing authorization for SYCREST for the treatment of moderate to severe manic episodes associated with bipolar I disorder in adults. The CHMP did not support an indication for the treatment of schizophrenia.

25 Jun 2010

HHS Secretary to speak about benefits of Affordable Care Act for women

Today, U.S. Secretary of Health and Human Services Secretary Kathleen Sebelius will speak to the National Partnership for Women and Families about how the Affordable Care Act will benefit women.

25 Jun 2010

PARP inhibitors may be effective in men with prostate cancer due to BRCA2 alteration: Researchers

The way prostate cancer develops in men who have an altered 'breast cancer gene' is the same route by which breast cancer develops in women with the same mutation, reveals a study published in PLoS Genetics today (Thursday).

25 Jun 2010

Nektar commences dosing in Phase 1 study of NKTR-102 in combination with 5-FU/leucovorin

Nektar Therapeutics announced today that the first patients have been dosed in a new Phase 1 dose-escalation clinical study to evaluate NKTR-102, the company's lead oncology compound, in combination with 5-fluorouracil (5-FU)/leucovorin in refractory solid tumor cancers. The study is being conducted at University Hospitals Case Medical Center of the Case Comprehensive Cancer Center in Cleveland, Ohio.

24 Jun 2010

Blood flow disturbances in artery determine appearance of atherosclerosis: Study

A new animal model of atherosclerosis has allowed researchers to identify a host of genes turned on or off during the initial stages of the process, before a plaque appears in the affected blood vessel.

24 Jun 2010

Hoag Hospital launches IORT program for breast cancer treatment

Hoag Hospital announced the launch of its Intraoperative Radiation Therapy program as part of its progressive, comprehensive approach to breast cancer treatment. IORT is a radiation therapy technique in which a concentrated dose of radiation is delivered to a cancerous tumor site during surgery after the tumor is removed. Hoag Hospital is the first in Orange County to offer IORT brachytherapy for breast cancer as a component of a definitive treatment approach.

24 Jun 2010

AVEO receives EMA orphan medicinal product designation for tivozanib

AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced it has received orphan medicinal product designation for tivozanib (N-{2-chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]phenyl}-N'-(5-methyl-3-isoxazolyl) urea hydrochloride monohydrate), its oral, triple VEGF receptor inhibitor, for the treatment of renal cell carcinoma by the European Medicines Agency (EMA).

24 Jun 2010

U.S. District Court Judge approves amended settlement in WTC litigation

At the conclusion of a hearing today, Judge Alvin K. Hellerstein of the U.S. District Court for the Southern District of New York signed an order approving the amended settlement reached among the WTC Captive Insurance Company (the "WTC Captive"), the City of New York, the contractors the City hired, their subcontractors, and attorneys for over 10,000 plaintiffs alleging injuries from the WTC site operations.

24 Jun 2010

UCSD School of Medicine receives $5.3M grant to study effect of weight loss in breast cancer survivors

The University of California, San Diego School of Medicine has received a $5.3 million grant from the National Cancer Institute to conduct and lead a first-of-its-kind, four-year clinical trial to show the effects of weight loss and increased physical activity on quality of life and on co-existing medical conditions in overweight breast cancer survivors.

24 Jun 2010

Researchers find way to get beneficial effects of estrogen without increasing woman's risk of cancer

Researchers at UT Southwestern Medical Center have pinpointed a set of biological mechanisms through which estrogen confers its beneficial effects on the cardiovascular system, independent of the hormone's actions on cancer. Their investigation suggests that drugs targeting a specific subpopulation of estrogen receptors found outside the cell nucleus might activate the cardiovascular benefits of estrogen without increasing cancer risk.

24 Jun 2010

UK cancer survival rates increase at 3% each year

The number of people who are living with and beyond cancer (cancer survivors) has risen, according to new figures from the National Cancer Intelligence Network.

23 Jun 2010

Toshiba announces availability of Aegis breast imaging workstation with MR products

Improving the ability to efficiently process MR images used for breast cancer analysis, the AegisTM breast imaging workstation is now available with Toshiba America Medical Systems' MR products. The Aegis workstation was developed with the distinct needs of radiologists and technologists in mind, offering flexibility and workflow efficiency.

23 Jun 2010

Endocrine Society presents Scientific Statement on menopausal hormone therapy at ENDO 2010

The Endocrine Society presented its Scientific Statement on menopausal hormone therapy Monday in San Diego, Calif. at ENDO 2010: The 92nd Annual Meeting & Expo.

23 Jun 2010

Recent objections would eliminate use of routine breast cancer screening mammograms: Authors

The firestorm that followed the November 2009 release of guidelines that would have reduced use of screening mammograms in women aged 40 to 49 highlights challenges for implementing the findings of comparative effectiveness research, according to a new analysis. Meeting such challenges - which may become more common due to increased funding for CER - requires better communication to the public and stakeholders about evidence and its connection to health care quality and efficiency.

23 Jun 2010

Cancer forms “intolerable burden” on the community: Health Minister

A new report reveals that here has been a 10 percent rise in cancer figures from 2006 in Australia. The figure translates to nearly 115,000 Australian cancer cases and 43,700 Australians are expected to die from the disease this year.

22 Jun 2010

Aurora Dedicated Breast MRI System installed at Ruijin Hospital, China

Aurora Imaging Technology, Inc. today announced the installation of the Aurora® Dedicated Breast MRI System in China at the world-renowned Ruijin Hospital located in Shanghai, the teaching hospital for China's top-tiered Jiao Tong University Medical School. The installation marks the first Aurora System in China.

22 Jun 2010

Ultrasound-guided diffuse optical tomography holds promise for ascertaining early-stage invasive breast cancer

By combining two relatively inexpensive technologies based on sound and light waves, researchers hope to lower the rate at which women undergo breast biopsies for suspicious lesions. Results of the study on ultrasound-guided optical tomography are published in the online edition and the August print issue of Radiology.

22 Jun 2010

FDA Advisory Committee recommendation against flibanserin will not affect LibiGel program: BioSante

BioSante Pharmaceuticals, Inc. commented today that the recommendation on June 18, 2010 by the FDA Advisory Committee regarding the safety and efficacy of flibanserin (Boehringer-Ingelheim) will have no impact on its own ongoing development program or approval pathway for LibiGel (testosterone gel), for the treatment of hypoactive sexual desire disorder (HSDD).

22 Jun 2010

Al Amal Hospital in Qatar commences treatment with Varian's RapidArc radiotherapy

One of the leading cancer centers in the Middle East has become among the first in the region to introduce fast and efficient RapidArc® radiotherapy treatments from Varian Medical Systems. Al Amal Hospital in Doha, Qatar, has treated nine brain cancer, prostate cancer and head & neck cancer patients with RapidArc since commencing treatments in early May, and it now plans to roll out the technology for many more indications.

21 Jun 2010

Independent DMC recommends continuation of BioSante's ongoing LibiGel CV and Breast Cancer Safety Study

BioSante Pharmaceuticals, Inc., today announced that the independent Data Monitoring Committee (DMC) of the ongoing LibiGel® Cardiovascular (CV) and Breast Cancer Safety Study unanimously recommended study continuation without modifications, after its third review of the study's unblinded safety data. The review was based on data from almost 1,500 women-years of exposure.

21 Jun 2010

Breast Cancer News and Research

Latest Breast Cancer News and Research

CHMP adopts positive opinion on pending MAA for SYCREST sublingual tablets

HHS Secretary to speak about benefits of Affordable Care Act for women

PARP inhibitors may be effective in men with prostate cancer due to BRCA2 alteration: Researchers

Nektar commences dosing in Phase 1 study of NKTR-102 in combination with 5-FU/leucovorin

Blood flow disturbances in artery determine appearance of atherosclerosis: Study

Hoag Hospital launches IORT program for breast cancer treatment

AVEO receives EMA orphan medicinal product designation for tivozanib

U.S. District Court Judge approves amended settlement in WTC litigation

UCSD School of Medicine receives $5.3M grant to study effect of weight loss in breast cancer survivors

Researchers find way to get beneficial effects of estrogen without increasing woman's risk of cancer

UK cancer survival rates increase at 3% each year

Toshiba announces availability of Aegis breast imaging workstation with MR products

Endocrine Society presents Scientific Statement on menopausal hormone therapy at ENDO 2010

Recent objections would eliminate use of routine breast cancer screening mammograms: Authors

Cancer forms “intolerable burden” on the community: Health Minister

Aurora Dedicated Breast MRI System installed at Ruijin Hospital, China

Ultrasound-guided diffuse optical tomography holds promise for ascertaining early-stage invasive breast cancer

FDA Advisory Committee recommendation against flibanserin will not affect LibiGel program: BioSante

Al Amal Hospital in Qatar commences treatment with Varian's RapidArc radiotherapy

Independent DMC recommends continuation of BioSante's ongoing LibiGel CV and Breast Cancer Safety Study

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Breast Cancer News and Research

Latest Breast Cancer News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in